Emergency treatment of acute symptomatic or ruptured abdominal aortic aneurysm. Outcome of a prospective intent-to-treat by EVAR protocol  by Peppelenbosch, N. et al.
Emergency Treatment of Acute Symptomatic or Ruptured Abdominal
Aortic Aneurysm. Outcome of a Prospective Intent-to-treat
by EVAR Protocol
N. Peppelenbosch1, N. Yilmaz1, C. van Marrewijk1, J. Buth1, Ph. Cuypers1,
L. Duijm2 and A. Tielbeek2
Departments of 1Surgery and 2Radiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands
Objective: outcome of treatment of patients with ruptured or symptomatic non-ruptured aneurysm (rAAA and snrAAA),
preferentially treated by emergency endovascular repair was assessed. The outcome was compared with a historical group of
patients treated by open repair.
Patients and methods: two groups of patients presenting with acute symptomatic AAA were compared. Group I (study
group) consisted of 40 consecutive prospectively enrolled patients from May 2001 until June 2002, in whom emergency
endovascular abdominal aortic aneurysm repair (e-EVAR) was the preferential management. Short or wide neck or profound
hypovolemic shock were exclusion criteria for e-EVAR. Group II (control group) consisted of 28 patients, retrospectively
analysed, all treated by conventional surgical repair between January 1999 and May 2001. In group I, 26 patients had
rAAA and in group II 22 patients. The other patients had snrAAA.
Results: in group I, 14 patients were treated by open repair. Unsuitable anatomy or profound hypovolemia was the cause of
open repair in eight patients, while logistic reasons were the reasons for use of open repair in six patients (off-protocol use of
open surgery). Thus, in this prospective series the feasibility of EVAR was 80% (32/40). Patient characteristics, proportion
rAAA or hemodynamically unstable patients were comparable in group I and II. Volume of blood loss and need for fluid
transfusion were significantly less in group I compared to group II. The perioperative mortality in group I was significantly
less than in group II (20% vs. 43%, respectively, p 0.04). If patients with rAAA were considered the mortality was 31%
in group I and 50% in group II, which difference did not reach the level of statistical significance.
Conclusion: e-EVAR was a feasible treatment in the majority of patients with rAAA and snrAAA. Blood loss and the
requirements of fluid transfusion were significantly decreased. Most importantly in this institutional series significantly
lower first-month mortality was observed in the group with preferential e-EVAR compared to a control group. A multi-
center study assessing the outcome of preferential use of e-EVAR in patients with acute symptomatic AAA is required.
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Introduction
A ruptured aneurysm of the abdominal aorta (rAAA)
is the 6th leading cause of acute death in the US.1 The
only treatment that may save a patient's life consisted
of emergency surgery with replacement of the rup-
tured aorta by a vascular prosthesis. Most published
data indicate a perioperative mortality of conventional
open surgery, which ranges from 32 to 70%.2±8 In a
recently published paper a gradual reduction of the
operative mortality over time was demonstrated until
a current rate of 41%.9 During the previous decade
the development of endovascular abdominal aortic
aneurysm repair (EVAR) has changed the practice
pattern of elective treatment in asymptomatic patients
considerably. EVAR has become a routine procedure
in many institutions, although statistical evidence of
decreased perioperative mortality is currently not
available. Nevertheless, it is considered by many the
treatment of choice in patients with increased risk of
conventional open surgery. In emergency repair of
patients with symptomatic non-ruptured abdominal
aortic aneurysms (snrAAA) stentgraft treatment may
have several advantages compared to an open proce-
dure. One aspect is the use of local anaesthesia rather
than general anaesthesia. It is believed that the
induction of general anaesthesia, which is associated
with the loss of arterial sympathetic tone, frequently
causes complete circulatory collapse in a patient with
severe hypovolemia and compensated shock. In addition
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relaxation of the abdominal wall may cause a con-
tained retroperitoneal rupture to turn into an open
intraperitoneal haemorrhage. The operative and
perioperative mortality increase dramatically with
massive blood loss in patients with a free intraperito-
neal rupture.2,3 The type of anaesthesia may be one of
the reasons of a possibly better outcome in endograft-
treated patients with ruptured AAA.
In the present report an analysis of our experience
with emergency-EVAR (e-EVAR) is presented. This
work differs from a previous preliminary publication
from our institution in that more patients were
included and the study group has been redefined.10 1
The objective of the present study involved the assess-
ment of the outcome of treatment in a consecutive
group of patients with symptomatic or ruptured AAA.
This approach allowed us to evaluate (1) the applic-
ability of e-EVAR, and (2) the possible impact of
e-EVAR on the early mortality in an unselected cohort
of patients with acute symptomatic aneurysms.
Methods
From May 2001 onward, patients with symptomatic
snrAAA and rAAA of the abdominal aorta presenting
at the Catharina Hospital, Eindhoven, The Netherlands,
were treated according to a well-defined management
protocol involving intent-to-treat by e-EVAR. Aneur-
ysms were considered symptomatic non-ruptured
(snrAAA), if there were no CT signs of haemorrhage
outside the wall of the aneurysm, but with acute pain
in the abdomen and an abdominal aneurysm, which
was painful at palpation. Aneurysms were defined
ruptured (rAAA) if there was extravasation of blood
surrounding the aneurysm at CT examination. In
patients that did not undergo CT examination a retro-
peritoneal haematoma at open surgery was the cri-
terion for rupture of the aneurysm. During the study
period all patients who were referred to our hospital
with a symptomatic aneurysm of the abdominal aorta,
were prospectively analysed and included in this
study.
On arrival in the emergency ward the intravenous
fluid infusion rate was minimised. The protocol
involved that patients were taken to the radiology
department for emergency CT examination with intra-
venous contrast infusion to opacify the aorta. An
exception was made for patients in profound shock
(systolic blood pressure 560 mmHg not responding
to rapid infusion of fluid) or who had a cardiac arrest
during transportation to the hospital, diameter and
length of the infrarenal neck of the aneurysm were
measured and the decision whether endovascular
repair was feasible was taken and communicated
with the operating room staff. Exclusion criteria for
e-EVAR were a short neck (less than 10 mm length), a
wide neck (over 30 mm in diameter) and inaccessible
iliac arteries. Following CT examination patients were
quickly transported to the operating room for the
selected emergency procedure, or taken to the inten-
sive care unit (ICU) for further optimalisation (only
in snrAAA). Patients with rupture of their aneurysm
were preferentially treated with an aorto-uni-iliac
endograft, combined with a crossover bypass (Fig. 1).
Details on the devices used were described in a
previous paper of our group.10
The study group described above was compared
with a control group of patients with a symptomatic
aneurysms, who were treated by open procedure,
between January 1999 and May 2001. This historical
control group was retrospectively analysed by hos-
pital chart review. Primary outcome events that were
compared included: 30-day or in-hospital mortality,
morbidity, length of hospital and ICU stay, intraopera-
tive blood loss, requirement of blood products and
overall fluid infusion during operation.
The follow-up protocol consisted of routine CT-
scanning at 1, 3, 6 and 12 months and hereafter every
year for patients treated with e-EVAR. Patients treated
by open surgery were seen back after 1 month and
3 months, hereafter yearly. Patients sent in from other
hospitals were readmitted back and have the same
schedule.
Statistical analysis was performed using SPSS1 for
Windows1 version 9.0. Chi-square and Fisher tests
were used for the comparison of discrete variables
and the Mann±Whitney test was used for continuous
variables. Continuous variables are presented as the
mean (range). A p-value of 50.05 was considered
significant.
Account of patient cohort in the present study and
control group relative to previous publication10
Of the 24 patients treated e-EVAR in the previous
assessment six were not considered in the present
study as they consisted a pilot phase and were
selected on favourite aspects. The cohort with con-
secutive enrolment with intend-to-treat by EVAR was
increased by eight EVAR patients (44% of previous
EVAR group), while 14 patients treated by open sur-
gery enrolled under the same protocol were also
1 A detailed account of patient cohort in the previous and present
analysis is presented in the methods section.
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Fig. 1. (a) Intraoperative angiogram demonstrating ruptured AAA. (b) Intraoperative angiogram demonstrating deployment of proximal
component of aorto-uni-iliac device. (c) Intraoperative angiogram demonstrating bilateral iliac arteries. (d) Postoperative CT-examination,
demonstrating functioning aorto-uni-iliac device with complete exclusion of the aneurysm.
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included for a total of 40 patients in the study group.
Six of these 14 patients were new enrolled patients
since the previous study.
The previous article included 40 patients with open
surgery of which eight felt within the intend-to-treat
by EVAR study period. Four additional patients with
open surgery were excluded (one because he had a
suture-line aneurysm and three with snrAAA because
they had been admitted longer than 24 h before treat-
ment), for a total of 28 patients constituting the present




From May 2001 until June 2002, 40 consecutive
patients in the study group were admitted and treated
in our hospital because of a ruptured or symptomatic
infrarenal abdominal aneurysm (group I, Table 1).
Twenty-six patients received endovascular repair
(EVAR subgroup), and 14 patients conventional open
surgery (COS subgroup, Table 2). There was a trend
that patients in the conventional group were hemo-
dynamic less stable and had larger aneurysms, how-
ever, these group differences in patient characteristics
were not significant (Table 2). The control group with
routine open repair consisted of 28 patients treated
between January 1999 and April 2001 (group II).
There were no significant differences with regard to
patient characteristics, presence of preoperative shock
or previous cardiac and/or pulmonary events, between
group I and II.
In the study group 14 (35%) patients had snrAAA
and 26 (65%) a rAAA, in the control group 6 (21%)
patients had a snrAAA and 22 (79%) a rAAA (Table 1).
The differences were not statistically significant. Of
the patients with a snrAAA two of the control group
and two of the study group were taken to the ICU and
treated within 24 h with an urgent operation. All other
16 snrAAA patients were treated without delay by
emergency operation.
In the study group 33 (83%) patients underwent
an emergency CT-scanning. Seven patients did not
undergo CT-scanning, three in the EVAR and four in
the COS subgroup. Reasons for not performing a CT-
scanning were profound hypovolemic shock (in two
patients) and logistic reasons in five patients. All these
patients were immediately transported to the operat-
ing room. In the three patients who received e-EVAR
fluoroscopic assessment was performed with cali-
brated catheters to establish the diameter of the neck
and neck length. In case open surgery was performed
fluoroscopic assessments were not performed. The
mean neck length was significantly longer in the
EVAR subgroup compared with the COS subgroup,
18.0 (6±36) and 7.5 (0±15) mm, respectively (p 0.004).
The neck diameter in the two subgroups was not stat-
istically different, 23.8 (17±33) and 27.8 (20±34) mm in
EVAR and COS, respectively.
Table 1. Patient characteristics in group I and II.
Group I study group (40 patients) Group II control group (28 patients)
Male/female N 34/6 22/6
Mean age (range) Years 73.0 (56.8±90.0) 73.2 (58.1±86.7)
SnrAAA/rAAA N 14/26 6/22
Mean  AAA (range) cm 7.0 (3.6±10.0) 7.5 (4.0±10.5)
Systolic 5100 mmHg N (%) 16 (40) 14 (56)
History of cardiac events N (%) 12 (30) 9 (32)
History of pulmonary events N (%) 7 (18) 6 (21)
Table 2. Patient characteristics of subgroups in group I (40 patients).
Subgroup with EVAR (26 pts) Subgroup with COS (14 pts)
Male/female N 23/3 11/3
Mean age (range) Years 74.1 (56.8±90.0) 71.0 (58.2±80.9)
SnrAAA/rAAA N 10/16 4/10
Mean  AAA (range) cm 6.7 (3.6±8.8) 7.7 (5.0±10.0)
Systolic 5100 mmHg N (%) 8 (31) 8 (57)
History of cardiac events N (%) 8 (31) 4 (29)
History of pulmonary events N (%) 6 (23) 1 (7)
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Applicability of e-EVAR
EVAR was performed in 26 of the 40 patients in the
study group. Reasons for COS were unavailable endo-
vascular specialists in six patients and unsuitable
anatomic (dimensions of the infrarenal neck, five
patients), or technical (profound hypovolemia, three
patients), reasons in eight patients. Thus the feasibility
of EVAR based on an acceptable aortoiliac anatomy
and hemodynamics was 80% (32/40). The overall
applicability of e-EVAR in this study was 65% (26/40).
Procedural details
The intraoperative and hospital aspects in group I and
II are summarised in Table 3. In the EVAR subgroup
no conversions to open surgery were required.
Most often an aorto-uni-iliac device was used in comb-
ination with a femorofemoral crossover bypass
(19 patients). Two patients received a tube-endograft
and five received a bifurcated stentgraft. Of the
patients who received a bifurcated stentgraft two
had a snrAAA. In 25 patients, a Talent
1
stentgraft
was used. In one patient a bifurcated Excluder
1
stentgraft was used. In 88% of the cases in the EVAR
subgroup, either local (in 15 patients) or regional (in
eight patients) anaesthesia was used. Two patients
with snrAAA and one with a rAAA received general
anaesthesia. The patient with ruptured aneurysm was
in deep hypovolemic shock at arrival in the hospital. It
was felt by the responsible anaesthesiologist that in
this patient a more rapid control of the hemodynamic
situation might be obtained by general anaesthesia.
Mean operation time was 155 (80±270) min in group I,
and 176 (100±240) in group II, which was not a
significant difference. Mean blood loss in group I
was 1800 (100±6000) ml, and in group II 3900
(300±12000) ml. This difference was statistically sig-
nificant (p 0.01). In addition, there was a significant
difference between group I and II with regard to total
fluid infusion (blood components, fresh frozen plasma
and crystalloids combined; p 0.004). Administration
of blood components was comparable in the two
groups.
Perioperative morbidity and mortality
The hospital and ICU-stay in the study group and
control group was not statistically different (Table 3).
The perioperative mortality rate in the study group
with preferential EVAR was significantly lower than
in group II, 20 and 43%, respectively, (p 0.04, Table 4).
If only patients with rupture of their aneurysms were
considered the mortality rate in group I was 31% and
in group II 50%. This difference did not reach the level
of statistical significance (p 0.10). Causes of death
included continued bleeding, cardiac failure, multi
organ failure, respiratory insufficiency and bowel
ischaemia. The latter constituted 50% (two patients)
of the causes of death in the EVAR subgroup. The rate
of postoperative morbidity among survivors was in
the study group higher than in the control group (44%
versus 25%, respectively) (Table 4). However, this dif-
ference did not reach statistical significance.
Follow-up of patients
In the EVAR subgroup, three patients demonstrated
an endoleak during follow-up from 30 days to
14 months: two patients had a type I and one patient
Table 3. Intraoperative and hospital characteristics in group I and II.
Study group (40 patients) Control group (28 pts)
Total (40 pts) EVAR (26 pts) COS (14 pts)
Mean operation time (range) Minutes 155 (80±270) 154 (80±270) 155 (90±240) 176 (100±240)
Anaesthesia
Local 15 15 ± ±
Regional 8 8 ± ±
General 17 3 14 28
Technique performed
Tube 11 2 9 21
Bifurcated 10 5 5 7
AUI crossover 19 19 ± ±
Mean blood loss (range) ml 1800 (100±6000) 1100 (100±2500) 2600 (500±6000) 3900 (300±12000)
Mean fluid infusion (range) ml 6600 (1500±20, 500)y 4700 (1500±12, 500) 10 400 (3400±20 500) 9000 (5000±13 700)
I.C.U. stay (range) Hours 81 (0±408) 46 (0±220) 154 (12±408) 122 (11±864)
Hospital stay (range) Days 12.3 (0±60) 7.2 (0±21) 22.1 (1±60) 13.0 (0±59)
 p5 0.01.
y p5 0.004 (numbers indicate patients unless stated otherwise).
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a type II endoleak. The latter patient is still under
survey and an intervention for coiling has been
planned. Both patients with type I endoleak refused
further intervention because of their age of, respec-
tively, 90 and 80 years. The 90-year old patient has a
follow-up time of 14 months and he remains without
symptoms. The 80-year old patient was discharged
from further follow-up on his own request.
Follow-up was achieved in 90% of the patients in
the study group and 86% in the control group. The
patients, with recorded follow-up data, were fol-
lowed in the hospitals from where they originally
were referred. The six-month survival in group I
was 74% and in group II 52% (Fig. 2). The differ-
ence of 22% already existed after the first post-
operative month and there was no further change
Table 4. Mortality and morbidity in group I and II.
Study group (40 patients) Control group (28 pts)
Total (40 pts) EVAR (26 pts) COS (14 pts)
Mortality (%) 8 (20)  4 4 12 (43)
Cardiac 2 ± 2 2
Pulmonary ± ± ± 1
Continued bleeding 2 1 1 1
Multiorgan failure 2 1 1 4
Bowel ischaemia 2 2 ± 3
Postoperative morbidity (%) of survivors 14 (44)  8 6 4 (25)
Cardiac 2 2 ± ±
Pulmonary 3 1 2 1
Multiorgan failure 1 ± 1 ±
Coagulation disorder ± ± ± 2
CVA 1 1 ± ±
Re-operation 3 ± 3 1
Wound infection/haematoma 4 4 ± ±
 p 0.04. p 0.3.
Fig. 2. Kaplan±Meier survival curves of patients in the study group and in the control group. Initially existing difference sustains during the
first months of follow-up. Numbers below figure indicate patients at risk.
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of this difference in the subsequent follow-up
period.
Discussion
Conventional open surgery has been the gold-
standard for the treatment of acute symptomatic
aneurysms for five decades.11 During this period the
perioperative mortality and morbidity has improved
only modestly.2±9 After the successful introduction of
elective stentgraft repair of asymptomatic abdominal
aneurysms,12±15 this technique now also is considered
appealing for the treatment of acute symptomatic
aneurysms.11,16,18 Mortality rates in these studies
range from 10 to 45%, which is promising considered
the prohibitive mortality in open surgery. However,
none of these studies was based on an intention-to-
treat by EVAR protocol or on a consecutively enrolled
patient group. Rather, patients were selected on the
basis of availability of experienced staff and other
practical aspects. Also in the previous report from
our group, Yilmaz assessed the outcome in a consecu-
tive series with regard to the treatment received,
patients with EVAR versus open repair. In the present
study, the larger and redefined study group allowed
to assess the overall impact of e-EVAR.
In the present study, group I consisting of both
patients with EVAR and COS and group II including
patients with open surgery, demonstrated less differ-
ence in preoperative characteristics than in our previ-
ous study because of redefined study groups. No
differences in operating time and ICU admission
time were noted between group I and II. Patient selec-
tion criteria for EVAR involved in the first place the
presence of a suitable infrarenal neck. This was appar-
ent in the study group from a significantly shorter
neck in the subgroup with COS compared to the sub-
group with EVAR.
The use of local rather than general anaesthesia may
be one of the important factors determining outcome
of treatment.17 In our study group, 58% received local
or regional anaesthesia. These types of anaesthesia do
not influence the tone of the abdominal wall. Relaxa-
tion of the abdominal musculature during general
anaesthesia may change a contained rupture into an
intraperitoneal or free rupture, reducing the chance of
survival significantly.3 Local anaesthesia has the addi-
tional advantage of leaving the sympathetic tone of
the arterioles unchanged. Patients with ruptured AAA
usually are in a state of compensated shock with max-
imal vasoconstriction. Release of the sympathetic tone
at induction of general anaesthesia may cause com-
plete cardiovascular collapse, as most of the surgeons
know from practical experience. Reduction of blood
loss and fluid administered during operation in the
EVAR subgroup are likely related to the avoidance
of general anaesthesia as much as to avoiding open
surgery.
Preoperative CT-scanning on the one hand appears
quite useful for ascertaining whether endovascular
treatment is feasible, and for measuring anatomical
dimensions. A drawback may be the time delay until
the treatment commences. In the present series only
two patients had too low blood pressures to allow an
additional delay of 10±15 min, which is the usual time
an emergency CT-scan takes in our institution. During
CT-examination the operating room is prepared for
the operative procedure, making the actual time
delay even less.
The use of aorto-uni-iliac rather than bifurcated
endografts is a matter of debate. During our institu-
tional experience we have developed a strong prefer-
ence for AUI-endografts. The advantages of this
device type include a quick introduction and deploy-
ment, which rapidly lowers intra-aneurysmal blood
pressure and provides control on the intra-abdominal
bleeding.19 Only one groin needs to be explored under
local anaesthesia, which seems more easily tolerated
by the patient in emergency circumstances than bilat-
eral groin exploitation. An additional advantage of
AUI grafts seems that patients with complex iliac
artery anatomy can more frequently be treated by
aorto-uni-iliac devices as only one suitable side is
needed. Nevertheless, Orend et al. and Lachat et al.
used bifurcated stentgrafts in their selected patient
population with comparable operating times and
excellent results.16,17
To demonstrate the impact of endograft treatment
on the first-month mortality of acute AAA requires a
careful analysis. Simple assessment EVAR-treated
patients will lead to a skewed outcome, as patients
with short necks or in profound shock will have the
highest risk, but will be excluded for EVAR. It is of
note that the present study is also the first to demon-
strate a significant difference in first-month mortality
in favour of e-EVAR compared to conventional sur-
gery in a combined group of patients with ruptured
and symptomatic AAAs. The advantage of e-EVAR
continues during the first postoperative months.
Apparently there is no catch-up of mortality by
delayed events and the favourable effect on survival
seems durable. Admittedly, our present follow-up
periods were still rather short. It is of note that the
incidence of postoperative complications among
survivors in group I was somewhat higher than in
group II. A plausible explanation may be that the
occurrence of complications in the first group was
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assessed prospectively and in the latter retrospectively.
Nevertheless, this finding also may indicate that com-
plications occur in patients with e-EVAR that may
cause death when open surgery would have been
performed.
The present study has several flaws. First, a rela-
tively small number of patients were included and the
follow-up period was short. Secondly, despite the
intent-to-treat by EVAR protocol six patients (15%)
received conventional open repair because of an
unavailable endovascular specialist at the time of
admission. When these patients also would have
been treated by EVAR, the difference in early mortal-
ity might have been even greater. Thirdly and perhaps
most importantly, the control group in this study was
analysed retrospectively, which may influence the
comparability with the study group as well as accur-
acy of recording events. A large scale multicenter
study is needed to confirm, that emergency EVAR
for acute symptomatic and ruptured aneurysms is
associated with improved survival. Once our findings
are confirmed by such a study, additional evidence
will be required from a randomised controlled trial
comparing EVAR and open surgery for clearly deli-
neated indications, distinguishing patients with truly
ruptured and symptomatic non-ruptured AAA. The
importance of a trial monitoring committee that ter-
minates the study as soon as a statistical significant
difference in operative survival is obtained at regular
interim analyses is obvious in such a RCT.
Late complications associated with e-EVAR
included the occurrence of endoleaks. In the present
study three endoleaks (12%) of survivors were pre-
sent after one month. Two patients had a type I
proximal endoleak, but refused further treatment.
So far they remained without symptoms. Never-
theless, these endoleaks in our opinion should be
treated either by the use of a giant Palmaz-stent,
an aortic extension endograft or by laparoscopic
banding of the aorta. The policy in type II endoleaks
may be similar as in elective EVAR and intervention
should be dependent on eventual increase in size of
the aneurysm.20
In conclusion, emergency endovascular repair of
ruptured and acute symptomatic abdominal aortic
aneurysms is justified when the patient has a suit-
able anatomy, most importantly an adequate infra-
renal neck. The first-month mortality in the present
study was significantly lower than in a control
group receiving surgical repair. Further study of a
larger study population to confirm our findings is
needed.
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